With three FcRn antagonists now approved, this novel treatment class is transforming the management of generalized myasthenia gravis (gMG). Are you prepared to integrate them into your clinical practice? In this rapid-fire, on-demand video, learn from expert Dr. Vera Bril as she explores the evolving role of FcRn antagonists in gMG management, including: The mechanism of action of FcRn antagonism An overview of the safety and efficacy of approved agents Summary strategies for applying FcRn antagonists in individualized treatment plans.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedNov 24, 2025
-
Last day to claim creditNov 24, 2026 6 weeks left
-
PVI, PeerView Institute for Medical Education Redefining Treatment Pathways in Generalized Myasthenia Gravis: Strengthening Clinician Expertise in Diagnosis and Personalized Care With FcRn Antagonists
-
DrBeen Corp H2 Receptor Antagonists (PM 9)
-
CME Outfitters, LLC Rethinking Suppression: GnRH Antagonists and Contemporary Endometriosis Management
-
PRIME Education, Inc. (PRIME®) Quick Case Challenge: Implementing FcRn Antagonists in gMG Practice
-
PRIME Education, Inc. (PRIME®) Myasthenia Gravis Beyond the Acetylcholine Receptor: Treatment Options, Emerging Evidence, and Individualized Care
-
PRIME Education, Inc. (PRIME®) Strategies for Personalized CIDP Care: Patient Selection, Treatment Transition, and FcRn Therapy
